Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial iron-binding proteins and microbial surface components (MSCRAMMs) represent a broad class of proteins located on the bacterial cell surface or secreted to facilitate survival and pathogenesis. Iron-binding proteins, including siderophore receptors and heme-binding proteins like IsdB, are essential for acquiring iron from host proteins such as transferrin and hemoglobin, a process vital for bacterial growth in the nutrient-limited host environment (Sheldon & Heinrichs, 2015, Frontiers in Cellular and Infection Microbiology). MSCRAMMs, such as protein A and fibronectin-binding proteins, mediate the initial attachment of bacteria to host extracellular matrix components like collagen and fibrinogen, which is a critical step for tissue colonization and biofilm formation (Foster et al., 2014, Nature Reviews Microbiology). These proteins also play significant roles in immune evasion by binding to host immunoglobulins or interfering with complement activation. Because of their accessibility on the cell surface, they are major targets for vaccine development and monoclonal antibody therapies, such as tefibazumab which targets the ClfA protein (Patti, 2004, Vaccine). Furthermore, the siderophore-mediated iron transport system is exploited by Trojan horse antibiotics like cefiderocol to bypass the bacterial outer membrane (Zhanel et al., 2019, Drugs). Despite their potential, the high degree of redundancy in these systems often allows bacteria to bypass specific blockades, presenting a significant challenge for drug efficacy.
Inhibition of bacterial adhesion to host tissues, blockade of essential iron uptake, and facilitation of opsonophagocytosis through antibody-mediated targeting.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial iron-binding proteins and microbial surface components (BIBPs and MSCRAMMs).